| Kentmere Rehabilitation And Healthcare Center | |
| 1900 Lovering Avenue, Wilmington, Delaware 19806 | |
| (302) 652-3311 | |
| Name | Kentmere Rehabilitation And Healthcare Center |
|---|---|
| Location | 1900 Lovering Avenue, Wilmington, Delaware |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 106 |
| Occupancy Rate | 84.53% |
| Medicare ID (CCN) | 085001 |
| Legal Business Name | Kentmere Home Of Merciful Rest Society Inc. |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1538151055 |
| Organization Name | KENTMERE HOME OF MERCIFUL REST SOCIETY INC. |
| Doing Business As | KENTMERE REHABILIATION AND HEALTHCARE CENTER INC. |
| Address | 1900 Lovering Ave, Wilmington, DE 19806 |
| Phone Number | 302-652-3311 |
News Archive
A fatty liver disease that is not well-known in overweight and obese children may be a precursor of cardiovascular disease, researchers reported in Circulation: Journal of the American Heart Association.
Despite numerous advances in treating infections and disease, effective treatments for sepsis remain elusive. A new discovery published in the June 2013 issue of The FASEB Journal not only could help health care providers predict who is more and less likely to develop sepsis, but it also opens the doors to new therapies that actually address the root cause of the problem, rather than just managing the symptoms.
U.S. residents have more confidence in President Obama than in some of his initiatives, such as the recently enacted economic stimulus plan and a proposal to raise taxes in order to expand health care coverage, according to a recent Wall Street Journal/NBC News poll, the Journal reports.
Based on POSSUM, a system suggested by some British scholars more than 10 years ago, a team led by Dr. Lian-An Ding has established the M-POSSUM evaluation system with the aim of improving the accuracy and effectiveness of the original system.
Interleukin Genetics, Inc. and LABEC Pharma, S.L. announced today that LABEC Pharma has met European regulatory guidelines to sell Interleukin Genetics' Heart Health genetic test. The test, which helps to identify individuals at elevated risk for early heart attack, will be marketed to physicians in Spain and Portugal by LABEC Pharma under the product name Cardio Health™.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A fatty liver disease that is not well-known in overweight and obese children may be a precursor of cardiovascular disease, researchers reported in Circulation: Journal of the American Heart Association.
Despite numerous advances in treating infections and disease, effective treatments for sepsis remain elusive. A new discovery published in the June 2013 issue of The FASEB Journal not only could help health care providers predict who is more and less likely to develop sepsis, but it also opens the doors to new therapies that actually address the root cause of the problem, rather than just managing the symptoms.
U.S. residents have more confidence in President Obama than in some of his initiatives, such as the recently enacted economic stimulus plan and a proposal to raise taxes in order to expand health care coverage, according to a recent Wall Street Journal/NBC News poll, the Journal reports.
Based on POSSUM, a system suggested by some British scholars more than 10 years ago, a team led by Dr. Lian-An Ding has established the M-POSSUM evaluation system with the aim of improving the accuracy and effectiveness of the original system.
Interleukin Genetics, Inc. and LABEC Pharma, S.L. announced today that LABEC Pharma has met European regulatory guidelines to sell Interleukin Genetics' Heart Health genetic test. The test, which helps to identify individuals at elevated risk for early heart attack, will be marketed to physicians in Spain and Portugal by LABEC Pharma under the product name Cardio Health™.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $226333 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 11.48 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 11.16 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 58.14 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.81 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.39 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.25 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.68 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 16.56 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 95.18 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.19 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 12.75 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 23.16 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 4.08 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.8 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 72.53 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 96.42 | 82.93 |
News Archive
A fatty liver disease that is not well-known in overweight and obese children may be a precursor of cardiovascular disease, researchers reported in Circulation: Journal of the American Heart Association.
Despite numerous advances in treating infections and disease, effective treatments for sepsis remain elusive. A new discovery published in the June 2013 issue of The FASEB Journal not only could help health care providers predict who is more and less likely to develop sepsis, but it also opens the doors to new therapies that actually address the root cause of the problem, rather than just managing the symptoms.
U.S. residents have more confidence in President Obama than in some of his initiatives, such as the recently enacted economic stimulus plan and a proposal to raise taxes in order to expand health care coverage, according to a recent Wall Street Journal/NBC News poll, the Journal reports.
Based on POSSUM, a system suggested by some British scholars more than 10 years ago, a team led by Dr. Lian-An Ding has established the M-POSSUM evaluation system with the aim of improving the accuracy and effectiveness of the original system.
Interleukin Genetics, Inc. and LABEC Pharma, S.L. announced today that LABEC Pharma has met European regulatory guidelines to sell Interleukin Genetics' Heart Health genetic test. The test, which helps to identify individuals at elevated risk for early heart attack, will be marketed to physicians in Spain and Portugal by LABEC Pharma under the product name Cardio Health™.
› Verified 6 days ago
Kentmere Rehabilitation And Healthcare Center Location: 1900 Lovering Avenue, Wilmington, Delaware 19806 Phone: (302) 652-3311 | |
Willowbrooke Court At Country House Location: 4830 Kennett Pike, Wilmington, Delaware 19807 Phone: (302) 654-5101 | |
Springs Rehabilitation At Brandywine Location: 505 Greenbank Road, Wilmington, Delaware 19808 Phone: (302) 998-0101 | |
Regency Healthcare & Rehab Center Location: 801 N. Broom Street, Wilmington, Delaware 19806 Phone: (302) 654-8400 | |
Complete Care At Hillside Llc Location: 810 South Broom Street, Wilmington, Delaware 19805 Phone: (302) 652-1181 |